Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit

Good morning, everyone.

I'm Neil Love from Research to Practice, and welcome to our fifth annual National General Medical Oncology Summit.

We're thrilled to be back here again working with the Florida Cancer Specialists.

We had a great program last night on lymphoma, and we have a lot of stuff to cover today and tomorrow.

We are really looking forward to this.

We have some fantastic faculty who have come here to Florida, almost 40 investigators, as well as a bunch of Florida cancer specialists who are going to join me here on the stage to co-moderate and ask questions, as we always like to do, of the investigators.

We're really grateful for their participation.

As always, we will be discussing the use of unapproved agents and regimens.

So check out the package inserts for more information.